Inactive Instrument

Insiders TCR2 Therapeutics Inc.

Equities

TCR2 Therapeutics Inc. Appoints Peter Olagunju as Chief Operating Officer	03/01/23	CI
TCR2 Therapeutics Appoints Eric Sullivan as Chief Financial Officer	27/06/22	MT
TCR2 Appoints Rosemary Harrison, Ph.D., as Chief Business and Strategy Officer	22/03/22	CI
TCR2 Therapeutics Inc. Announces Appointment of Rosemary Harrison as Chief Business and Strategy Officer	13/01/22	CI
TCR2 Therapeutics Appoints Chief Business and Strategy Officer	12/01/22	MT
TCR2 Therapeutics Inc. Announces Board Changes	26/08/21	CI
TCR² Therapeutics Appoints Peter Olagunju as Chief Technical Officer	20/07/21	CI
TCR2 Therapeutics Inc. Appoints Shawn Tomasello to Board of Directors, Compensation Committee and Nominating and Corporate Governance Committee	04/02/21	CI
TCR2 Therapeutics Inc. Hires Gregg McConnell as Head of Business Development	27/05/20	CI
TCR2 Therapeutics Inc. Announces Change of Board of Directors	04/05/20	CI
TCR2Therapeutics Inc. Appoints Axel Hoos to Its Board of Directors	15/04/20	CI
TCR2Therapeutics Appoints Angela Justice as Chief People Officer	09/10/19	CI
TCR2Therapeutics Inc. Announces Executive Appointments	06/08/19	CI
TCR2 Therapeutics Appoints Andrew Allen, M.D., Ph.D. to the Board of Directors	19/12/18	CI
TCR2 Therapeutics Inc. Appoints Ian Somaiya as Chief Financial Officer	10/04/18	CI
TCR2 Therapeutics Inc. Appoints Dr. Stephan Grupp to Advisory Board	02/11/17	CI
TCR2 Therapeutics Announces Management Appointments	11/10/17	CI

No results for this search